We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Onset Genes for Alzheimer's and Parkinson's Located

By Biotechdaily staff writers
Posted on 21 May 2002
Researchers from Duke University Medical Center (Durham NC, USA; www.mc.duke.edu) have identified a group of chromosomal regions that could be responsible for controlling the onset of Alzheimer's or Parkinson's disease. More...
The study, designed to test the hypothesis that the same set of genes might control the onset of two disorders that share some common features, appears in the April 2002 issue of the American Journal of Human Genetics.

As part of the study the researchers performed a genomic screen--the first ever designed to study age at onset of the two disorders--of 449 families with multiple family members with Alzheimer's disease and 174 families with multiple family members with Parkinson's disease. Past research had shown that chromosome 10 could contain a risk gene for Alzheimer's disease. The current study shows that chromosome 10 could contain an age-at-onset gene that affects both Alzheimer's and Parkinson's diseases. Strong evidence was also found for an age-at-onset gene for Parkinson's on chromosome 1.

The age of onset of Alzheimer's disease is generally considered the time at which an individual begins to suffer short-term memory loss or disorientation in a manner serious enough to interfere with daily activities. The average age at onset for individuals in the study was 72.8 years for Alzheimer's disease and 60.1 years for Parkinson's disease.

"The finding is significant because until now, geneticists have focused their attention on identifying individual genes that control the risk of developing a disease,” says Margaret Pericak-Vance, Ph.D., director of the Center for Human Genetics at Duke and principal investigator of the study. "Risk is only one mode of genetic expression. Age at onset of disease can also be genetically influenced. Understanding the regulation of onset will open new avenues of research that could one day make it possible to delay onset beyond an individual's normal lifespan.”




Related Links:
Duke University Medical Center

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.